Surgery Partners Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,344	3,309	3,114	2,743	2,539	2,225
Revenue Growth (YoY)	5.38%	6.24%	13.52%	8.03%	14.12%	19.62%
Cost of Revenue	2,580	2,544	2,369	2,096	1,964	1,734
Gross Profit	763.3	765	745.6	647.5	574.9	491.4
Selling, General & Admin	121.5	118.2	138.7	120.9	102.2	104
Depreciation & Amortization Expenses	178.2	176	152.6	118.1	114.8	98.8
Other Operating Expenses	70.2	81.3	105.5	80.5	12.7	24.3
Total Operating Expenses	369.9	375.5	396.8	319.5	229.7	227.1
Operating Income	393.4	389.5	348.8	328	345.2	302.2
Interest Income	21.4	22.9	19.5	14.2	12.5	11.3
Interest Expense	-279.5	-272.6	-201.7	-193	-234.9	-221
Other Non-Operating Income (Expense)	-21.4	-22.9	-19.5	-14.2	-12.5	26.6
Total Non-Operating Income (Expense)	-279.5	-272.6	-201.7	-193	-234.9	-183.1
Pretax Income	113.9	116.9	147.1	135	110.3	81.2
Provision for Income Taxes	16.8	18	134.6	-0.3	23.3	10.5
Net Income	97.1	98.9	12.5	135.3	87	70.7
Minority Interest in Earnings	173.2	176.8	180.6	147.2	141.6	141.6
Net Income Attributable to Preferred Dividends	-	-	-	-	-	-10.3
Net Income to Common	-76.1	-77.9	-168.1	-11.9	-54.6	-152.1
Shares Outstanding (Basic)	128	127	126	126	92	72
Shares Outstanding (Diluted)	128	127	126	126	92	72
Shares Change (YoY)	1.08%	0.86%	0.40%	36.61%	26.96%	48.49%
EPS (Basic)	-0.60	-0.61	-1.33	-0.09	-0.59	-1.12
EPS (Diluted)	-0.60	-0.61	-1.33	-0.09	-0.59	-1.12
Free Cash Flow	208	195.6	209.7	205	78.2	29.5
Free Cash Flow Growth	6.34%	-6.72%	2.29%	162.15%	165.08%	-85.54%
Free Cash Flow Per Share	1.63	1.54	1.66	1.63	0.85	0.41
Gross Margin	22.83%	23.12%	23.94%	23.60%	22.64%	22.08%
Operating Margin	11.77%	11.77%	11.20%	11.96%	13.59%	13.58%
Profit Margin	2.90%	2.99%	0.40%	4.93%	3.43%	3.18%
FCF Margin	6.22%	5.91%	6.73%	7.47%	3.08%	1.33%
EBITDA	571.6	565.5	501.4	446.1	460	401
EBITDA Margin	17.10%	17.09%	16.10%	16.26%	18.12%	18.02%
EBIT	393.4	389.5	348.8	328	345.2	302.2
EBIT Margin	11.77%	11.77%	11.20%	11.96%	13.59%	13.58%
Effective Tax Rate	14.75%	15.40%	91.50%	-0.22%	21.12%	12.93%

SEC Filings: 10-K · 10-Q